Standards of Medical Care in Diabetes—2012
暂无分享,去创建一个
[1] D. Birch,et al. Cost-effectiveness of bariatric surgery for severely obese adults with diabetes. , 2013, Canadian journal of surgery. Journal canadien de chirurgie.
[2] T. Ohara. [Glucose tolerance status and risk of dementia in the community: the Hisayama study]. , 2013, Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica.
[3] M. Özkaya,et al. Action to Control Cardiovascular Risk in Diabetes , 2013 .
[4] William Weintraub,et al. Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy. , 2011, The New England journal of medicine.
[5] M. Craig,et al. Microvascular complications assessment in adolescents with 2‐ to 5‐yr duration of type 1 diabetes from 1990 to 2006 , 2011, Pediatric diabetes.
[6] Christos Davatzikos,et al. Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy , 2011, The Lancet Neurology.
[7] A. Peters,et al. Diabetes Care for Emerging Adults: Recommendations for Transition From Pediatric to Adult Diabetes Care Systems , 2011, Diabetes Care.
[8] A Eugene Washington,et al. The Patient-Centered Outcomes Research Institute--promoting better information, decisions, and health. , 2011, The New England journal of medicine.
[9] S. Kripalani,et al. Health Literacy Explains Racial Disparities in Diabetes Medication Adherence , 2011, Journal of health communication.
[10] E. Ragazzi,et al. New International Association of the Diabetes and Pregnancy Study Groups (IADPSG) recommendations for diagnosing gestational diabetes compared with former criteria: a retrospective study on pregnancy outcome , 2011, Diabetic medicine : a journal of the British Diabetic Association.
[11] B. Stetson,et al. Assessing the Value of the Diabetes Educator , 2011, The Diabetes educator.
[12] R. Cebul,et al. Electronic health records and quality of diabetes care. , 2011, The New England journal of medicine.
[13] D. Cutler,et al. The ACO rules--striking the balance between participation and transformative potential. , 2011, The New England journal of medicine.
[14] Peter C. Austin,et al. Deriving Ethnic-Specific BMI Cutoff Points for Assessing Diabetes Risk , 2011, Diabetes Care.
[15] C. Richardson,et al. Comparison of Hemoglobin A1c With Fasting Plasma Glucose and 2-h Postchallenge Glucose for Risk Stratification Among Women With Recent Gestational Diabetes Mellitus , 2011, Diabetes Care.
[16] Kamlesh Khunti,et al. Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial , 2011, The Lancet.
[17] S. Saydah,et al. Long-Term and Recent Progress in Blood Pressure Levels Among U.S. Adults With Diagnosed Diabetes, 1988–2008 , 2011, Diabetes Care.
[18] Russell E. Glasgow,et al. Diabetes Performance Measures: Current Status and Future Directions , 2011, Diabetes Care.
[19] Leila C. Kahwati,et al. Survival among high-risk patients after bariatric surgery. , 2011, JAMA.
[20] C. Cardwell,et al. Clinical and metabolic effects of gluten free diet in children with type 1 diabetes and coeliac disease , 2011, Pediatric diabetes.
[21] E. Vittinghoff,et al. Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes. , 2011, JAMA.
[22] S. Suh,et al. Diabetes and Cancer: Is Diabetes Causally Related to Cancer? , 2011, Diabetes & metabolism journal.
[23] E. Ford. Trends in the Risk for Coronary Heart Disease Among Adults With Diagnosed Diabetes in the U.S. , 2011, Diabetes Care.
[24] E. Agardh,et al. Adopting 3-Year Screening Intervals for Sight-Threatening Retinal Vascular Lesions in Type 2 Diabetic Subjects Without Retinopathy , 2011, Diabetes Care.
[25] Sally A. Kraft,et al. Minority Status and Diabetes Screening in an Ambulatory Population , 2011, Diabetes Care.
[26] R. Hermida,et al. Influence of Time of Day of Blood Pressure–Lowering Treatment on Cardiovascular Risk in Hypertensive Patients With Type 2 Diabetes , 2011, Diabetes Care.
[27] H. Hoffman,et al. Risk Factors for Hearing Impairment Among U.S. Adults With Diabetes , 2011, Diabetes Care.
[28] Nisa M. Maruthur,et al. Comparative Effectiveness and Safety of Medications for Type 2 Diabetes: An Update Including New Drugs and 2-Drug Combinations , 2011, Annals of Internal Medicine.
[29] E. Rico,et al. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care. , 2011, Journal of hospital medicine.
[30] S. Yusuf,et al. Incidence of Diabetes Following Ramipril or Rosiglitazone Withdrawal , 2011, Diabetes Care.
[31] M. Rewers,et al. Additional Autoimmune Disease Found in 33% of Patients at Type 1 Diabetes Onset , 2011, Diabetes Care.
[32] I. Hirsch,et al. Individualizing Glycemic Targets in Type 2 Diabetes Mellitus: Implications of Recent Clinical Trials , 2011, Annals of Internal Medicine.
[33] F. Dunne,et al. Atlantic Diabetes in Pregnancy (DIP): the prevalence and outcomes of gestational diabetes mellitus using new diagnostic criteria , 2011, Diabetologia.
[34] E. Feldman,et al. Evidence-based guideline: Treatment of painful diabetic neuropathy , 2011, Neurology.
[35] A. Farmer,et al. Point-of-care testing for Hb A1c in the management of diabetes: a systematic review and metaanalysis. , 2011, Clinical chemistry.
[36] M. Phillip,et al. Effect of Continuous Glucose Monitoring on Hypoglycemia in Type 1 Diabetes , 2011, Diabetes Care.
[37] M. Rosal,et al. Randomized Trial of a Literacy-Sensitive, Culturally Tailored Diabetes Self-Management Intervention for Low-Income Latinos , 2011, Diabetes Care.
[38] Robert A. Gabbay,et al. Patient-Centered Medical Home and Diabetes , 2011, Diabetes Care.
[39] L. Ruilope,et al. Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes. , 2011, The New England journal of medicine.
[40] Michael E. Miller,et al. Long-Term Effects of Intensive Glucose Lowering on Cardiovascular Outcomes , 2011 .
[41] Elizabeth Selvin,et al. Racial Differences in Glycemic Markers: A Cross-sectional Analysis of Community-Based Data , 2011, Annals of Internal Medicine.
[42] J. Rosenbauer,et al. Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes , 2011, Pediatric diabetes.
[43] Limin Peng,et al. Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) , 2011, Diabetes Care.
[44] 久雄 小川. Japanese Primary Prevention of Atherosclerosis with Aspirin for Diabetes(JPAD)Trial , 2011 .
[45] R. Grant,et al. Diabetes Oral Medication Initiation and Intensification , 2011, The Diabetes educator.
[46] Paul E. Johnson,et al. Impact of Electronic Health Record Clinical Decision Support on Diabetes Care: A Randomized Trial , 2011, The Annals of Family Medicine.
[47] Å. Lernmark,et al. Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus , 2002, Diabetes Care.
[48] C. Lebrun,et al. Exercise and Type 2 Diabetes: American College of Sports Medicine and the American Diabetes Association: Joint Position Statement , 2011 .
[49] G L Viviani,et al. Recommendations for the use of cardiovascular tests in diagnosing diabetic autonomic neuropathy. , 2011, Nutrition, metabolism, and cardiovascular diseases : NMCD.
[50] E. Ford. Trends in the Risk for Coronary Heart Disease Among AdultsWith Diagnosed Diabetes in the U.S. Findings from the National Health and Nutrition Examination Survey, 1999–2008 , 2011 .
[51] Do Peterson,et al. Collaborative care for patients with depression and chronic illnesses. , 2010, The New England journal of medicine.
[52] Sarah M. Greene,et al. Twelve evidence-based principles for implementing self-management support in primary care. , 2010, Joint Commission journal on quality and patient safety.
[53] B. Fernhall,et al. Exercise and Type 2 Diabetes , 2010, Diabetes Care.
[54] K. Robinson,et al. Clinical Care Guidelines for Cystic Fibrosis–Related Diabetes , 2010, Diabetes Care.
[55] Neil M. Johannsen,et al. Effects of aerobic and resistance training on hemoglobin A1c levels in patients with type 2 diabetes: a randomized controlled trial. , 2010, JAMA.
[56] J. Piette,et al. Diabetes Control With Reciprocal Peer Support Versus Nurse Care Management , 2010, Annals of Internal Medicine.
[57] Dolores Corella,et al. Reduction in the Incidence of Type 2 Diabetes With the Mediterranean Diet , 2010, Diabetes Care.
[58] Dean Schillinger,et al. Language Barriers, Physician-Patient Language Concordance, and Glycemic Control Among Insured Latinos with Diabetes: The Diabetes Study of Northern California (DISTANCE) , 2010, Journal of General Internal Medicine.
[59] Rena R Wing,et al. Long-term effects of a lifestyle intervention on weight and cardiovascular risk factors in individuals with type 2 diabetes mellitus: four-year results of the Look AHEAD trial. , 2010, Archives of internal medicine.
[60] K. Kaukinen,et al. Celiac disease without villous atrophy in children: a prospective study. , 2010, The Journal of pediatrics.
[61] David C Klonoff,et al. Assisted Monitoring of Blood Glucose: Special Safety Needs for a New Paradigm in Testing Glucose , 2010, Journal of diabetes science and technology.
[62] N. K. de Vries,et al. Self-management interventions for type 2 diabetes: a systematic review , 2010 .
[63] Rodica Pop-Busui,et al. Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial , 2010, The Lancet.
[64] W. Willett,et al. Sugar-Sweetened Beverages and Risk of Metabolic Syndrome and Type 2 Diabetes , 2010, Diabetes Care.
[65] T. Wadden,et al. Weight and Metabolic Outcomes After 2 Years on a Low-Carbohydrate Versus Low-Fat Diet , 2010, Annals of Internal Medicine.
[66] M. DiNardo,et al. Menu selection, glycaemic control and satisfaction with standard and patient-controlled consistent carbohydrate meal plans in hospitalised patients with diabetes , 2010, Quality and Safety in Health Care.
[67] M. Makary,et al. Medication utilization and annual health care costs in patients with type 2 diabetes mellitus before and after bariatric surgery. , 2010, Archives of surgery.
[68] Ping Zhang,et al. Cost-Effectiveness of Interventions to Prevent and Control Diabetes Mellitus: A Systematic Review , 2010, Diabetes Care.
[69] Enrico Cagliero,et al. Effectiveness of a Computerized Insulin Order Template in General Medical Inpatients With Type 2 Diabetes , 2010, Diabetes Care.
[70] George Dailey,et al. Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. , 2010, The New England journal of medicine.
[71] Richard J McManus,et al. Telemonitoring and self-management in the control of hypertension (TASMINH2): a randomised controlled trial , 2010, The Lancet.
[72] Walter T Ambrosius,et al. Effects of medical therapies on retinopathy progression in type 2 diabetes. , 2010, The New England journal of medicine.
[73] G. Bakris,et al. Tight blood pressure control and cardiovascular outcomes among hypertensive patients with diabetes and coronary artery disease. , 2010, JAMA.
[74] Lukasz Januszkiewicz. [The ACCORD Study Group. Effects of combination lipid therapy in type 2 diabetes mellitus]. , 2010, Kardiologia polska.
[75] Chaoyang Li,et al. Prevalence of self-reported clinically diagnosed sleep apnea according to obesity status in men and women: National Health and Nutrition Examination Survey, 2005-2006. , 2010, Preventive medicine.
[76] D. Williamson,et al. A1C Level and Future Risk of Diabetes: A Systematic Review , 2010, Diabetes Care.
[77] Viola Vaccarino,et al. Glucose-Independent, Black–White Differences in Hemoglobin A1c Levels , 2010, Annals of Internal Medicine.
[78] M. Pellen,et al. Preoperative Factors Predicting Remission of Type 2 Diabetes Mellitus After Roux-en-Y Gastric Bypass Surgery for Obesity , 2010, Obesity surgery.
[79] D. Giugliano,et al. Effects of a Mediterranean-Style Diet on the Need for Antihyperglycemic Drug Therapy in Patients With Newly Diagnosed Type 2 Diabetes: A Randomized Trial , 2010 .
[80] M. Heisler,et al. Different models to mobilize peer support to improve diabetes self-management and clinical outcomes: evidence, logistics, evaluation considerations and needs for future research. , 2010, Family practice.
[81] Anil Bhansali,et al. Utility of glycated hemoglobin in diagnosing type 2 diabetes mellitus: a community-based study. , 2010, The Journal of clinical endocrinology and metabolism.
[82] V. Montori,et al. Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline. , 2010, The Journal of clinical endocrinology and metabolism.
[83] P. Wilson,et al. Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes , 2010, Diabetes Care.
[84] A. Thanopoulou,et al. Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults. , 2010, The New England journal of medicine.
[85] Jacob E. Kurlander,et al. Self-management support in "real-world" settings: an empowerment-based intervention. , 2010, Patient education and counseling.
[86] W. Ambrosius,et al. Epidemiologic Relationships Between A1C and All-Cause Mortality During a Median 3.4-Year Follow-up of Glycemic Treatment in the ACCORD Trial , 2010, Diabetes Care.
[87] John B Buse,et al. Effects of combination lipid therapy in type 2 diabetes mellitus. , 2010, The New England journal of medicine.
[88] Kevin A Peterson,et al. Effects of Intensive Blood-Pressure Control in Type 2 Diabetes Mellitus , 2011 .
[89] Justin Feigelman,et al. Age at initiation and frequency of screening to detect type 2 diabetes: a cost-effectiveness analysis , 2010, The Lancet.
[90] Wendy Macdonald,et al. Identifying Psychosocial Interventions That Improve Both Physical and Mental Health in Patients With Diabetes , 2010, Diabetes Care.
[91] Daren Anderson,et al. Self-Management Goal Setting in a Community Health Center: The Impact of Goal Attainment on Diabetes Outcomes , 2010, Diabetes Spectrum.
[92] D. Mager,et al. Testosterone Concentrations in Diabetic and Nondiabetic Obese Men , 2010, Diabetes Care.
[93] M. Hadamitzky,et al. Prognostic Value of Coronary Computed Tomographic Angiography in Diabetic Patients Without Known Coronary Artery Disease , 2010, Diabetes Care.
[94] Catherine L. Liang,et al. Effects of a computerized order set on the inpatient management of hyperglycemia: a cluster-randomized controlled trial. , 2010, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[95] Bengt Persson,et al. International Association of Diabetes and Pregnancy Study Groups Recommendations on the Diagnosis and Classification of Hyperglycemia in Pregnancy , 2010, Diabetes Care.
[96] C. Davis,et al. Disordered Eating Behavior in Individuals With Diabetes , 2010, Diabetes Care.
[97] R. Glasgow,et al. The Relationship Between Diabetes Distress and Clinical Depression With Glycemic Control Among Patients With Type 2 Diabetes , 2010, Diabetes Care.
[98] Tanya K Bubner,et al. Point-of-care testing for patients with diabetes, hyperlipidaemia or coagulation disorders in the general practice setting: a systematic review. , 2010, Family practice.
[99] E. Ford,et al. Prevalence of Diabetes and High Risk for Diabetes Using A1C Criteria in the U.S. Population in 1988–2006 , 2010, Diabetes Care.
[100] Michael E. Miller,et al. The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study , 2010, BMJ : British Medical Journal.
[101] Michael A Weiss,et al. National Standards for Diabetes Self-Management Education , 2010, Diabetes Care.
[102] P. O S I T I O N S T A T E M E N T,et al. Diagnosis and Classification of Diabetes Mellitus , 2011, Diabetes Care.
[103] F. Ovalle. 10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study , 2010 .
[104] Michael E. Miller,et al. ACTION TO CONTROL CARDIOVASCULAR RISK IN DIABETES STUDY GROUP. EFFECTS OF INTENSIVE GLUCOSE LOWERING IN TYPE 2 DIABETES , 2010 .
[105] V. Sánchez. Long-Term Effect of Diabetes and Its Treatment on Cognitive Function , 2010 .
[106] A. Fanaroff. A Multicenter, Randomized Trial of Treatment for Mild Gestational Diabetes , 2010 .
[107] W. Elliott. Effect of Candesartan on Microalbuminuria and Albumin Excretion Rate in Diabetes: Three Randomized Trials , 2010 .
[108] B. Gersh. Cardiac Outcomes After Screening for Asymptomatic Coronary Artery Disease in Patients With Type 2 Diabetes The DIAD Study: A Randomized Controlled Trial , 2010 .
[109] M. Sevick,et al. Active Care Management Supported by Home Telemonitoring in Veterans With Type 2 Diabetes , 2009, Diabetes Care.
[110] C. Abraira,et al. Veterans Affairs diabetes trial--corrections. , 2009, The New England journal of medicine.
[111] R. Freeman. Not all neuropathy in diabetes is of diabetic etiology: Differential diagnosis of diabetic neuropathy , 2009, Current diabetes reports.
[112] D. Wile,et al. Association of Metformin, Elevated Homocysteine, and Methylmalonic Acid Levels and Clinically Worsened Diabetic Peripheral Neuropathy , 2009, Diabetes Care.
[113] J. J. Rivera,et al. Assessment of subclinical coronary atherosclerosis in asymptomatic patients with type 2 diabetes mellitus with single photon emission computed tomography and coronary computed tomography angiography. , 2009, The American journal of cardiology.
[114] Howard Wolpert,et al. Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group. The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2009 .
[115] D. Sherr,et al. Assessing the Value of Diabetes Education , 2009, The Diabetes educator.
[116] A. Hattersley,et al. The diagnosis and management of monogenic diabetes in children and adolescents , 2009, Pediatric diabetes.
[117] Thomas E. Moritz,et al. Intensive glucose control and macrovascular outcomes in type 2 diabetes , 2009, Diabetologia.
[118] Robert J. Anderson,et al. Intensive Glucose-Lowering Therapy Reduces Cardiovascular Disease Events in Veterans Affairs Diabetes Trial Participants With Lower Calcified Coronary Atherosclerosis , 2009, Diabetes.
[119] B. Zinman,et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years' duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). , 2009, Archives of internal medicine.
[120] H. Parving,et al. Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials. , 2009, Annals of internal medicine.
[121] Samy Suissa,et al. Renal and retinal effects of enalapril and losartan in type 1 diabetes. , 2009, The New England journal of medicine.
[122] Sigridur Sia Jonsdottir,et al. Hyperglycemia and Adverse Pregnancy Outcomes , 2009 .
[123] J. Shaw,et al. International Expert Committee Report on the Role of the A1C Assay in the Diagnosis of Diabetes , 2009, Diabetes Care.
[124] J. N. Fisher,et al. Hyperglycemic Crises in Adult Patients With Diabetes , 2009, Diabetes Care.
[125] A. Moran,et al. Cystic Fibrosis–Related Diabetes: Current Trends in Prevalence, Incidence, and Mortality , 2009, Diabetes Care.
[126] Maria Mori Brooks,et al. A randomized trial of therapies for type 2 diabetes and coronary artery disease. , 2009, The New England journal of medicine.
[127] P. Raskin,et al. Patient‐directed titration for achieving glycaemic goals using a once‐daily basal insulin analogue: an assessment of two different fasting plasma glucose targets ‐ the TITRATETM study , 2009, Diabetes, obesity & metabolism.
[128] Richard Hellman,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[129] R. Collins,et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. , 2009, Lancet.
[130] Darrell M. Wilson,et al. The effect of continuous glucose monitoring in well-controlled type 1 diabetes , 2010 .
[131] Mary T Korytkowski,et al. American Association of Clinical Endocrinologists and American Diabetes Association consensus statement on inpatient glycemic control. , 2009, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists.
[132] P. Sham,et al. Diabetes prevalence and therapeutic target achievement in the United States, 1999 to 2006. , 2009, The American journal of medicine.
[133] Kristine Yaffe,et al. Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus. , 2009, JAMA.
[134] E. Barrett,et al. Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial. , 2009, JAMA.
[135] Deborah J. Cook,et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data , 2009, Canadian Medical Association Journal.
[136] T. Sugimoto,et al. Diabetic Patients Have an Increased Risk of Vertebral Fractures Independent of BMD or Diabetic Complications , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[137] G. Umpierrez. Basal Versus Sliding-Scale Regular Insulin in Hospitalized Patients With Hyperglycemia During Enteral Nutrition Therapy , 2009, Diabetes Care.
[138] F. Toledo,et al. Insulin Therapy and Glycemic Control in Hospitalized Patients With Diabetes During Enteral Nutrition Therapy , 2009, Diabetes Care.
[139] Stephane Heritier,et al. Intensive versus conventional glucose control in critically ill patients. , 2009, The New England journal of medicine.
[140] David Kelley,et al. Obstructive Sleep Apnea Among Obese Patients With Type 2 Diabetes , 2009, Diabetes Care.
[141] M. Jensen,et al. Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. , 2009, The American journal of medicine.
[142] D. Nathan. Medical Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy: A Consensus Statement of the American Diabetes Association and the European Association for the Study of Diabetes , 2009, Diabetes Care.
[143] P. Wilson,et al. Effects of Prandial Versus Fasting Glycemia on Cardiovascular Outcomes in Type 2 Diabetes: The HEART2D trial , 2009, Diabetes Care.
[144] Jennifer Schore,et al. Effects of care coordination on hospitalization, quality of care, and health care expenditures among Medicare beneficiaries: 15 randomized trials. , 2009, JAMA.
[145] R. Hanås,et al. A 2‐yr national population study of pediatric ketoacidosis in Sweden: predisposing conditions and insulin pump use , 2009, Pediatric diabetes.
[146] M. Davidson. How Our Current Medical Care System Fails People With Diabetes , 2009, Diabetes Care.
[147] M. Moodie,et al. Cost-Efficacy of Surgically Induced Weight Loss for the Management of Type 2 Diabetes , 2009, Diabetes Care.
[148] Stephen Colagiuri,et al. Individual patient education for people with type 2 diabetes mellitus. , 2009, The Cochrane database of systematic reviews.
[149] Grant D. Huang,et al. Glucose control and vascular complications in veterans with type 2 diabetes. , 2009, The New England journal of medicine.
[150] S. Rodriguez-Segade,et al. Translating the A1C Assay Into Estimated Average Glucose Values , 2009, Diabetes Care.
[151] B. Howard,et al. Intensive Glycemic Control and the Prevention of Cardiovascular Events: Implications of the ACCORD, ADVANCE, and VA Diabetes Trials , 2009, Diabetes Care.
[152] J. Simon. Diabetes Glycaemic Education and Monitoring Trial Group , 2009 .
[153] Brian T. Austin,et al. Evidence on the Chronic Care Model in the new millennium. , 2009, Health affairs.
[154] Quinn A. Czosnowski,et al. Evaluation of glycemic control following discontinuation of an intensive insulin protocol. , 2009, Journal of hospital medicine.
[155] K. Resch. [Dietary Intervention Randomized Controlled Trial (DIRECT) group: weight loss with a low-carbohydrate, Mediterranean, or low-fat diet]. , 2008, Forschende Komplementarmedizin.
[156] S. Fowler,et al. Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions. , 2008, The Journal of clinical endocrinology and metabolism.
[157] F. McAlister,et al. A randomized trial of the effect of community pharmacist and nurse care on improving blood pressure management in patients with diabetes mellitus: study of cardiovascular risk intervention by pharmacists-hypertension (SCRIP-HTN). , 2008, Archives of internal medicine.
[158] T. Morimoto,et al. Low-Dose Aspirin for Primary Prevention of Atherosclerotic Events in Patients With Type 2 Diabetes , 2012 .
[159] L. Carter-Edwards,et al. Community health ambassadors: a model for engaging community leaders to promote better health in North Carolina. , 2008, Journal of public health management and practice : JPHMP.
[160] J. Vergnes,et al. Efficacy of periodontal treatment on glycaemic control in diabetic patients: A meta-analysis of interventional studies. , 2008, Diabetes & metabolism.
[161] P. Macfarlane,et al. The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease , 2008, BMJ : British Medical Journal.
[162] R. Holman,et al. 10-year follow-up of intensive glucose control in type 2 diabetes. , 2008, The New England journal of medicine.
[163] Michael O'Grady,et al. Continuous glucose monitoring and intensive treatment of type 1 diabetes. , 2008, The New England journal of medicine.
[164] N. Barnard,et al. Changes in nutrient intake and dietary quality among participants with type 2 diabetes following a low-fat vegan diet or a conventional diabetes diet for 22 weeks. , 2008, Journal of the American Dietetic Association.
[165] D. Marrero,et al. Translating the Diabetes Prevention Program into the community. The DEPLOY Pilot Study. , 2008, American journal of preventive medicine.
[166] S. Yusuf,et al. Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial , 2008, The Lancet.
[167] Blackford Middleton,et al. Practice-linked online personal health records for type 2 diabetes mellitus: a randomized controlled trial. , 2008, Archives of internal medicine.
[168] Vicki S Conn,et al. Meta-analysis of Quality of Life Outcomes Following Diabetes Self-management Training , 2008, The Diabetes educator.
[169] S. Humphries,et al. Coronary calcium measurement improves prediction of cardiovascular events in asymptomatic patients with type 2 diabetes: the PREDICT study. , 2008, European heart journal.
[170] Renda Soylemez Wiener,et al. Ill Adults: A Meta-analysis Benefits and Risks of Tight Glucose Control in Critically , 2010 .
[171] Michael J. Mueller,et al. Comprehensive Foot Examination and Risk Assessment , 2008, Diabetes Care.
[172] D. Schoenfeld,et al. Translating the A1C Assay Into Estimated Average Glucose Values , 2008, Diabetes Care.
[173] H. Pincus,et al. Depression and Diabetes: A Potentially Lethal Combination , 2008, Journal of General Internal Medicine.
[174] M. Stampfer,et al. Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet. , 2008, The New England journal of medicine.
[175] Rebecca Cannings-John,et al. Culturally appropriate health education for type 2 diabetes mellitus in ethnic minority groups. , 2008, The Cochrane database of systematic reviews.
[176] Nilay D Shah,et al. Chronic care model and shared care in diabetes: randomized trial of an electronic decision support system. , 2008, Mayo Clinic proceedings.
[177] Naresh M Punjabi,et al. Sleep-disordered breathing and type 2 diabetes: a report from the International Diabetes Federation Taskforce on Epidemiology and Prevention. , 2008, Diabetes research and clinical practice.
[178] Howard J Hoffman,et al. Diabetes and Hearing Impairment in the United States: Audiometric Evidence from the National Health and Nutrition Examination Survey, 1999 to 2004 , 2008, Annals of Internal Medicine.
[179] David B Sacks,et al. A new look at screening and diagnosing diabetes mellitus. , 2008, The Journal of clinical endocrinology and metabolism.
[180] Eve Roelker. Screening for Coronary Artery Disease in Patients With Diabetes , 2008 .
[181] Michael E. Miller,et al. Effects of intensive glucose lowering in type 2 diabetes. , 2008, The New England journal of medicine.
[182] Diederick Grobbee,et al. Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes. , 2008, The New England journal of medicine.
[183] E. Lewis,et al. Aliskiren combined with losartan in type 2 diabetes and nephropathy. , 2008, The New England journal of medicine.
[184] Bo Zhang,et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study , 2008, The Lancet.
[185] Li-sheng Liu,et al. Treatment of hypertension in patients 80 years of age or older. , 2008, The New England journal of medicine.
[186] R. Glasgow,et al. Where Is the Patient in Diabetes Performance Measures? , 2008, Diabetes Care.
[187] A. Farmer,et al. Cost effectiveness of self monitoring of blood glucose in patients with non-insulin treated type 2 diabetes: economic evaluation of data from the DiGEM trial , 2008, BMJ : British Medical Journal.
[188] M. O'Kane,et al. Efficacy of self monitoring of blood glucose in patients with newly diagnosed type 2 diabetes (ESMON study): randomised controlled trial , 2008, BMJ : British Medical Journal.
[189] E. Vivian,et al. Effects of Pharmacist Outpatient Interventions on Adults with Diabetes Mellitus: A Systematic Review , 2008, Pharmacotherapy.
[190] V. Valdmanis,et al. Nutritionist Visits, Diabetes Classes, and Hospitalization Rates and Charges , 2008, Diabetes Care.
[191] Curt D. Furberg,et al. Lipoprotein Management in Patients With Cardiometabolic Risk , 2008, Diabetes Care.
[192] Darrell M. Wilson,et al. Relationship of A1C to Glucose Concentrations in Children With Type 1 Diabetes , 2008, Diabetes Care.
[193] O. Pedersen,et al. Effect of a multifactorial intervention on mortality in type 2 diabetes. , 2008, The New England journal of medicine.
[194] Catherine M Champagne,et al. The evidence for dietary prevention and treatment of cardiovascular disease. , 2008, Journal of the American Dietetic Association.
[195] Arleen F. Brown,et al. Perception of Neighborhood Problems, Health Behaviors, and Diabetes Outcomes Among Adults With Diabetes in Managed Care , 2008, Diabetes Care.
[196] Margaret Anderson,et al. Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. , 2008, JAMA.
[197] Rolf Rossaint,et al. Intensive insulin therapy and pentastarch resuscitation in severe sepsis. , 2008, The New England journal of medicine.
[198] Judith Wylie-Rosett,et al. Nutrition Recommendations and Interventions for Diabetes , 2008, Diabetes Care.
[199] J. Leahy. Impaired Fasting Glucose and Impaired Glucose Tolerance: Implications for care , 2008 .
[200] D. Dempsey,et al. Effects of Bariatric Surgery on Mortality in Swedish Obese Subjects , 2008 .
[201] W. Howard. Effect of Lowering LDL Cholesterol Substantially Below Currently Recommended Levels in Patients With Coronary Heart Disease and Diabetes: The Treating to New Targets (TNT) study , 2008 .
[202] N. Khardori. Intensive Insulin Therapy and Pentastarch Resuscitation in Severe Sepsis , 2008 .
[203] Richard Hellman,et al. Comprehensive foot examination and risk assessment. A report of the Task Force of the Foot Care Interest Group of the American Diabetes Association, with endorsement by the American Association of Clinical Endocrinologists. , 2008, Physical therapy.
[204] G. Davı̀,et al. Platelet activation and atherothrombosis. , 2007, The New England journal of medicine.
[205] Yuh-Min Song,et al. Faculty Opinions recommendation of Resolution of asymptomatic myocardial ischemia in patients with type 2 diabetes in the Detection of Ischemia in Asymptomatic Diabetics (DIAD) study. , 2007 .
[206] M. Parchman,et al. Risk of Coronary Artery Disease in Type 2 Diabetes and the Delivery of Care Consistent With the Chronic Care Model in Primary Care Settings: A STARNet Study , 2007, Medical care.
[207] E. Fisher,et al. Healthy Coping, Negative Emotions, and Diabetes Management , 2007, The Diabetes educator.
[208] G Foster,et al. Self-management education programmes by lay leaders for people with chronic conditions. , 2007, The Cochrane database of systematic reviews.
[209] William Caplan,et al. Weight-loss outcomes: a systematic review and meta-analysis of weight-loss clinical trials with a minimum 1-year follow-up. , 2007, Journal of the American Dietetic Association.
[210] J. Krinsley,et al. Severe hypoglycemia in critically ill patients: Risk factors and outcomes* , 2007, Critical care medicine.
[211] H. Buchwald,et al. Trends in mortality in bariatric surgery: a systematic review and meta-analysis. , 2007, Surgery.
[212] R. Rubin,et al. Behavioral and Psychosocial Interventions in Diabetes , 2007, Diabetes Care.
[213] B. Anderson,et al. Transitioning From Pediatric to Adult Care , 2007, Diabetes Care.
[214] Anushka Patel,et al. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial , 2007, The Lancet.
[215] Walter C Willett,et al. Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture. , 2007, American journal of epidemiology.
[216] Claude Bouchard,et al. Effects of bariatric surgery on mortality in Swedish obese subjects. , 2007, The New England journal of medicine.
[217] Inder Singh,et al. High-density lipoprotein as a therapeutic target: a systematic review. , 2007, JAMA.
[218] P. Mehler,et al. Appropriate blood pressure control in hypertensive and normotensive type 2 diabetes mellitus: a summary of the ABCD trial , 2007, Nature Clinical Practice Nephrology.
[219] John D. Piette,et al. Beyond Comorbidity Counts: How Do Comorbidity Type and Severity Influence Diabetes Patients’ Treatment Priorities and Self-Management? , 2007, Journal of General Internal Medicine.
[220] S. Vale. Clinical Depression Versus Distress Among Patients With Type 2 Diabetes: Not Just a Question of Semantics , 2007, Diabetes Care.
[221] J. Mahoney,et al. Glucose Measurement: Confounding Issues in Setting Targets for Inpatient Management , 2007, Diabetes Care.
[222] Elizabeth Goyder,et al. Impact of self monitoring of blood glucose in the management of patients with non-insulin treated diabetes: open parallel group randomised trial , 2007, BMJ : British Medical Journal.
[223] Jeffrey A. Feinstein,et al. Noninherited Risk Factors and Congenital Cardiovascular Defects: Current Knowledge: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young , 2007, Circulation.
[224] L. Fogelfeld,et al. Gain in patients' knowledge of diabetes management targets is associated with better glycemic control. , 2007, Diabetes Care.
[225] Susan Smyth,et al. Aspirin dose for the prevention of cardiovascular disease: a systematic review. , 2007, JAMA.
[226] P. Cleary,et al. Long-term effect of diabetes and its treatment on cognitive function. , 2007, The New England journal of medicine.
[227] Rajiv Raman,et al. The Sensitivity and Specificity of Nonmydriatic Digital Stereoscopic Retinal Imaging in Detecting Diabetic Retinopathy , 2007, Diabetes Care.
[228] Andrea M. Wessell,et al. Different Paths to High-Quality Care: Three Archetypes of Top-Performing Practice Sites , 2007, The Annals of Family Medicine.
[229] D. Berman,et al. Optimal medical therapy with or without PCI for stable coronary disease. , 2007, The New England journal of medicine.
[230] Marc S Jacobson,et al. Drug therapy of high-risk lipid abnormalities in children and adolescents: a scientific statement from the American Heart Association Atherosclerosis, Hypertension, and Obesity in Youth Committee, Council of Cardiovascular Disease in the Young, with the Council on Cardiovascular Nursing. , 2007, Circulation.
[231] G. Bray,et al. Reduction in Weight and Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes , 2007, Diabetes Care.
[232] M. Fisher,et al. Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) , 2007 .
[233] Fernando Costa,et al. Primary Prevention of Cardiovascular Diseases in People With Diabetes Mellitus , 2007, Diabetes Care.
[234] J. Bosch,et al. Association of diabetes‐related emotional distress with diabetes treatment in primary care patients with Type 2 diabetes , 2007, Diabetic medicine : a journal of the British Diabetic Association.
[235] C. Feifer,et al. Improving Diabetes Care Through a Multicomponent Quality Improvement Model in a Practice-Based Research Network , 2007, American journal of medical quality : the official journal of the American College of Medical Quality.
[236] W. Howard. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2007 .
[237] J. Stockman. Effect of Treatment of Gestational Diabetes Mellitus on Pregnancy Outcomes , 2007 .
[238] J. Boucher,et al. Inpatient management of diabetes and hyperglycemia: implications for nutrition practice and the food and nutrition professional. , 2007, Journal of the American Dietetic Association.
[239] P. Vestergaard,et al. Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes—a meta-analysis , 2007, Osteoporosis International.
[240] Kathleen N Lohr,et al. Systematic Review: Smoking Cessation Intervention Strategies for Adults and Adults in Special Populations , 2006, Annals of Internal Medicine.
[241] J. Lindström,et al. Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.
[242] D. Mikhailidis,et al. Efficacy and Safety of Atorvastatin in the Prevention of Cardiovascular End Points in Subjects With Type 2 Diabetes: The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN) , 2006, Diabetes Care.
[243] Rodney A Hayward,et al. Narrative Review: Lack of Evidence for Recommended Low-Density Lipoprotein Treatment Targets: A Solvable Problem , 2006, Annals of Internal Medicine.
[244] Desmond E. Williams,et al. The Burden of Diabetes Mellitus Among US Youth: Prevalence Estimates From the SEARCH for Diabetes in Youth Study , 2006, Pediatrics.
[245] M. Laakso,et al. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial , 2006, The Lancet.
[246] J. Stradling,et al. Prevalence of obstructive sleep apnoea in men with type 2 diabetes , 2006, Thorax.
[247] S. Braithwaite,et al. Effects of outcome on in-hospital transition from intravenous insulin infusion to subcutaneous therapy. , 2006, The American journal of cardiology.
[248] K. Shojania,et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. , 2006, JAMA.
[249] A. Mooradian,et al. Narrative Review: A Rational Approach to Starting Insulin Therapy , 2006, Annals of Internal Medicine.
[250] Lawrence A Leiter,et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines , 2006, Current opinion in cardiology.
[251] S. Hernández-Díaz,et al. Major congenital malformations after first-trimester exposure to ACE inhibitors. , 2006, The New England journal of medicine.
[252] M. Phillip,et al. Insulin Pump Therapy in Youth With Type 1 Diabetes: A Retrospective Paired Study , 2006, Pediatrics.
[253] G. Van den Berghe,et al. Intensive insulin therapy in the medical ICU. , 2006, The New England journal of medicine.
[254] T. Horsley,et al. Effectiveness of community health workers in the care of persons with diabetes , 2006, Diabetic medicine : a journal of the British Diabetic Association.
[255] G. Remuzzi,et al. Prevention and treatment of diabetic renal disease in type 2 diabetes: the BENEDICT study. , 2006, Journal of the American Society of Nephrology : JASN.
[256] Michael Pignone,et al. Aspirin, Statins, or Both Drugs for the Primary Prevention of Coronary Heart Disease Events in Men: A CostUtility Analysis , 2006, Annals of Internal Medicine.
[257] Matthias Briel,et al. Effects of low-carbohydrate vs low-fat diets on weight loss and cardiovascular risk factors: a meta-analysis of randomized controlled trials. , 2006, Archives of internal medicine.
[258] R. Hamman,et al. Testing the accelerator hypothesis: body size, beta-cell function, and age at onset of type 1 (autoimmune) diabetes. , 2006, Diabetes care.
[259] James Albers,et al. Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. , 2006, Diabetes care.
[260] P. Scheltens,et al. Risk of dementia in diabetes mellitus: a systematic review , 2006, The Lancet Neurology.
[261] A. Avogaro,et al. Detection of coronary artery disease in asymptomatic patients with type 2 diabetes mellitus. , 2006, Journal of the American College of Cardiology.
[262] Y. Khader,et al. Periodontal status of diabetics compared with nondiabetics: a meta-analysis. , 2006, Journal of diabetes and its complications.
[263] L. Gaetke,et al. A single nutrition counseling session with a registered dietitian improves short-term clinical outcomes for rural Kentucky patients with chronic diseases. , 2006, Journal of the American Dietetic Association.
[264] C. Snehalatha,et al. The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1) , 2006, Diabetologia.
[265] B. Zinman,et al. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. , 2005, The New England journal of medicine.
[266] H. Parving,et al. Beneficial impact of spironolactone in diabetic nephropathy. , 2005, Kidney international.
[267] P Glasziou,et al. Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial , 2005, The Lancet.
[268] J. Williamson,et al. Cognitive decline and dementia in diabetes—systematic overview of prospective observational studies , 2005, Diabetologia.
[269] R. Collins,et al. Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.
[270] R. Collins,et al. Reduction in cardiovascular events with atorvastatin in 2,532 patients with type 2 diabetes: Anglo-Scandinavian Cardiac Outcomes Trial--lipid-lowering arm (ASCOT-LLA). , 2005, Diabetes care.
[271] Sally Morton,et al. Meta-Analysis: Chronic Disease Self-Management Programs for Older Adults , 2005, Annals of Internal Medicine.
[272] Katsuhiko Kuwa,et al. Approved IFCC recommendation on reporting results for blood glucose (abbreviated). , 2005, Clinical chemistry.
[273] G. Pacini,et al. The relative benefits of endurance and strength training on the metabolic factors and muscle function of people with type 2 diabetes mellitus. , 2005, Archives of physical medicine and rehabilitation.
[274] H. Kramer,et al. Screening for kidney disease in adults with diabetes. , 2005, Diabetes care.
[275] A. Swerdlow,et al. Psychosocial and socioeconomic risk factors for premature death in young people with type 1 diabetes. , 2005, Diabetes care.
[276] J. Hiller,et al. Effect of treatment of gestational diabetes mellitus on pregnancy outcomes. , 2005, The New England journal of medicine.
[277] L. Bouter,et al. Self-monitoring of blood glucose in patients with type 2 diabetes who are not using insulin: a systematic review. , 2005, Diabetes care.
[278] M. C. Leske,et al. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: the Barbados Eye Studies. , 2005, Ophthalmology.
[279] A. Marian,et al. Pharmacogenetic study of statin therapy and cholesterol reduction. , 2005, Current atherosclerosis reports.
[280] J. Cade,et al. Group based training for self-management strategies in people with type 2 diabetes mellitus. , 2005, The Cochrane database of systematic reviews.
[281] Roberto Sega,et al. Prognostic Value of Ambulatory and Home Blood Pressures Compared With Office Blood Pressure in the General Population: Follow-Up Results From the Pressioni Arteriose Monitorate e Loro Associazioni (PAMELA) Study , 2005, Circulation.
[282] H. Parving,et al. Dual Blockade of the Renin-angiotensin-aldosterone System in Diabetic Nephropathy: The Role of Aldosterone , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[283] C. Perlemoine,et al. Estimation of glomerular filtration rate in diabetic subjects: Cockcroft formula or modification of Diet in Renal Disease study equation? , 2005, Diabetes care.
[284] S. Norris,et al. Depressive symptoms and mortality among persons with and without diabetes. , 2005, American journal of epidemiology.
[285] J. Rosenstock,et al. Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes. , 2005, Diabetes care.
[286] Dan Ziegler,et al. Diabetic neuropathies: a statement by the American Diabetes Association. , 2005, Diabetes care.
[287] H. Mcdonald,et al. Effects of computerized clinical decision support systems on practitioner performance and patient outcomes: a systematic review. , 2005, JAMA.
[288] C. Hanis,et al. Dosage effects of diabetes self-management education for Mexican Americans: the Starr County Border Health Initiative. , 2005, Diabetes care.
[289] Stephen W. Sorensen,et al. The Cost-Effectiveness of Lifestyle Modification or Metformin in Preventing Type 2 Diabetes in Adults with Impaired Glucose Tolerance , 2005, Annals of Internal Medicine.
[290] W. Herman,et al. The efficacy and cost of alternative strategies for systematic screening for type 2 diabetes in the U.S. population 45-74 years of age. , 2005, Diabetes care.
[291] W. A. Müller,et al. Metabolic and hormonal effects of muscular exercise in juvenile type diabetics , 1977, Diabetologia.
[292] L. Hsc. Hyperglycemia, blood pressure, and the 9-year incidence of diabetic retinopathy: The Barbados Eye Studies , 2005 .
[293] M. Davidson,et al. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. , 2005, The American journal of cardiology.
[294] H. Ando,et al. Oxytocin-induced prostaglandin E2 (PGE2) synthesis is regulated by progesterone via oxytocinase in Ishikawa cells. , 2005, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.
[295] C. Schmid,et al. Long-term effectiveness of weight-loss interventions in adults with pre-diabetes: a review. , 2005, American journal of preventive medicine.
[296] Robert M. Anderson,et al. Evaluating a problem-based empowerment program for African Americans with diabetes: results of a randomized controlled trial. , 2005, Ethnicity & disease.
[297] B. Anderson,et al. Care of children and adolescents with type 1 diabetes: a statement of the American Diabetes Association. , 2005, Diabetes care.
[298] M. Palta,et al. Outcomes monitoring of health, behavior, and quality of life after nutrition intervention in adults with type 2 diabetes. , 2004, Journal of the American Dietetic Association.
[299] A. Häkkinen,et al. Brain Metabolic Alterations in Patients with Type 1 Diabetes–Hyperglycemia-Induced Injury , 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[300] Jonathan J Shuster,et al. Radial artery tonometry demonstrates arterial stiffness in children with type 1 diabetes. , 2004, Diabetes care.
[301] M. Pfeffer,et al. Angiotensin-converting-enzyme inhibition in stable coronary artery disease. , 2004, The New England journal of medicine.
[302] F. Kaufman,et al. Early onset of subclinical atherosclerosis in young persons with type 1 diabetes. , 2004, The Journal of pediatrics.
[303] Carmen Castaneda-Sceppa,et al. Physical activity/exercise and type 2 diabetes. , 2004, Diabetes care.
[304] M. Pfeffer,et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. , 2004, JAMA.
[305] John H Fuller,et al. Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial , 2004, The Lancet.
[306] Christopher P Cannon,et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. , 2004, The New England journal of medicine.
[307] Daniel H Solomon,et al. Self-management education programs in chronic disease: a systematic review and methodological critique of the literature. , 2004, Archives of internal medicine.
[308] Judith Wylie-Rosett,et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies: a statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. , 2004, Diabetes care.
[309] Judith Wylie-Rosett,et al. Weight management through lifestyle modification for the prevention and management of type 2 diabetes: rationale and strategies. A statement of the American Diabetes Association, the North American Association for the Study of Obesity, and the American Society for Clinical Nutrition. , 2004, The American journal of clinical nutrition.
[310] E. Barrett,et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. , 2004, Diabetes care.
[311] H. Büller,et al. Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study , 2004, JAMA.
[312] Neil J Stone,et al. Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines , 2004, Circulation.
[313] C. Schmid,et al. Efficacy of pharmacotherapy for weight loss in adults with type 2 diabetes mellitus: a meta-analysis. , 2004, Archives of internal medicine.
[314] K. Borch-Johnsen,et al. Preventive cardiology: abstractVery low levels of microalbuminuria are associated with increased risk of coronary heart disease and death independently of renal function, hypertension, and diabetes☆ , 2004 .
[315] W. Tamborlane,et al. A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. , 2004, Diabetes care.
[316] Mark R Conaway,et al. Translating lifestyle intervention to practice in obese patients with type 2 diabetes: Improving Control with Activity and Nutrition (ICAN) study. , 2004, Diabetes care.
[317] M. Rewers,et al. Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. , 2004, Diabetes care.
[318] P. Cryer. Diverse causes of hypoglycemia-associated autonomic failure in diabetes. , 2004, The New England journal of medicine.
[319] E. Gracely,et al. The Effects of Low-Carbohydrate versus Conventional Weight Loss Diets in Severely Obese Adults: One-Year Follow-up of a Randomized Trial , 2004, Annals of Internal Medicine.
[320] Paul Schoenhagen,et al. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis: a randomized controlled trial. , 2004, JAMA.
[321] M. Rewers,et al. Celiac disease associated with type 1 diabetes mellitus. , 2004, Endocrinology and metabolism clinics of North America.
[322] M. Porta,et al. A 5-year randomized controlled study of learning, problem solving ability, and quality of life modifications in people with type 2 diabetes managed by group care. , 2004, Diabetes care.
[323] H. El‐Serag,et al. Diabetes increases the risk of chronic liver disease and hepatocellular carcinoma. , 2004, Gastroenterology.
[324] Irl B Hirsch,et al. Management of diabetes and hyperglycemia in hospitals. , 2004, Diabetes care.
[325] Theodore Speroff,et al. Diabetes patient education: a meta-analysis and meta-regression. , 2004, Patient education and counseling.
[326] M. Mcmahon,et al. Diabetes nutrition recommendations for health care institutions. , 2004, Diabetes care.
[327] L. Aiello,et al. Retinopathy in diabetes. , 2004, Diabetes care.
[328] Carl J Pepine,et al. A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. , 2003, JAMA.
[329] Richard A Jackson,et al. Integrating medical management with diabetes self-management training: a randomized control trial of the Diabetes Outpatient Intensive Treatment program. , 2003, Diabetes care.
[330] J. Shaw,et al. Follow-up report on the diagnosis of diabetes mellitus. , 2003, Diabetes care.
[331] Lee Hebert,et al. Proteinuria and other markers of chronic kidney disease: a position statement of the national kidney foundation (NKF) and the national institute of diabetes and digestive and kidney diseases (NIDDK). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[332] Karl Swedberg,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function taking angiotensin-converting-enzyme inhibitors: the CHARM-Added trial , 2003, The Lancet.
[333] M. Pfeffer,et al. Effects of candesartan in patients with chronic heart failure and reduced left-ventricular systolic function intolerant to angiotensin-converting-enzyme inhibitors: the CHARM-Alternative trial , 2003, The Lancet.
[334] M. Pfeffer,et al. Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM-Overall programme , 2003, The Lancet.
[335] Malinda Peeples,et al. Diabetes Self-Management Education Core Outcomes Measures , 2003, The Diabetes educator.
[336] Stanton Newman,et al. A systematic review of psychosocial outcomes following education, self-management and psychological interventions in diabetes mellitus. , 2003, Patient education and counseling.
[337] Effects of clinical nutrition education and educator discipline on glycemic control outcomes in the Indian health service. , 2003, Diabetes care.
[338] G. Eknoyan,et al. National Kidney Foundation Practice Guidelines for Chronic Kidney Disease: Evaluation, Classification, and Stratification , 2003, Annals of Internal Medicine.
[339] R. Sigal,et al. Meta-analysis of the effect of structured exercise training on cardiorespiratory fitness in Type 2 diabetes mellitus , 2003, Diabetologia.
[340] P. Heagerty,et al. Daily weight-bearing activity does not increase the risk of diabetic foot ulcers. , 2003, Medicine and science in sports and exercise.
[341] B. McCrindle,et al. Efficacy and safety of atorvastatin in children and adolescents with familial hypercholesterolemia or severe hyperlipidemia: a multicenter, randomized, placebo-controlled trial. , 2003, The Journal of pediatrics.
[342] Quan Dong Nguyen,et al. Renal insufficiency in the absence of albuminuria and retinopathy among adults with type 2 diabetes mellitus. , 2003, JAMA.
[343] Sarah Parish,et al. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial , 2003, The Lancet.
[344] P. Cryer,et al. Hypoglycemia in diabetes. , 2003, Diabetes care.
[345] D. Rader,et al. A randomized trial of a low-carbohydrate diet for obesity. , 2003, The New England journal of medicine.
[346] Daniel W. Jones,et al. The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. , 2003, JAMA.
[347] I. Hirsch,et al. Outpatient insulin therapy in type 1 and type 2 diabetes mellitus: scientific review. , 2003, JAMA.
[348] Care California Healthcare Foundation/American Geriatri. Guidelines for Improving the Care of the Older Person with Diabetes Mellitus , 2003 .
[349] F. Brancati,et al. The prevalence and etiology of elevated aminotransferase levels in the United States , 2003, American Journal of Gastroenterology.
[350] Keith C. Norris,et al. A Systematic Review of Diabetes Self-Care Interventions for Older, African American, or Latino Adults , 2003, The Diabetes educator.
[351] E. Guallar,et al. Meta-Analysis of Randomized Educational and Behavioral Interventions in Type 2 Diabetes , 2003, The Diabetes educator.
[352] C. Mangione,et al. Guidelines for improving the care of the older person with diabetes mellitus. , 2003, Journal of the American Geriatrics Society.
[353] M. Pfeffer,et al. Cardiovascular Outcomes in the Irbesartan Diabetic Nephropathy Trial of Patients with Type 2 Diabetes and Overt Nephropathy , 2003, Annals of Internal Medicine.
[354] L. Phillips,et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. , 2003, Diabetes care.
[355] S. Lewington. Prospective studies collaboration. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies (vol 360, pg 1903, 2002) , 2003 .
[356] D. Schillinger,et al. Closing the loop: physician communication with diabetic patients who have low health literacy. , 2003, Archives of internal medicine.
[357] G. Braden. Cardiovascular outcomes in the Irbesartan Diabetic Nephropathy Trial of patients with type 2 diabetes and overt nephropathy. , 2003 .
[358] Adverse Events after Hospital Discharge , 2003, Annals of Internal Medicine.
[359] Peripheral Arterial Disease in People With Diabetes , 2003 .
[360] D. Nathan,et al. Randomized controlled community-based nutrition and exercise intervention improves glycemia and cardiovascular risk factors in type 2 diabetic patients in rural Costa Rica. , 2003, Diabetes care.
[361] J. Kastelein,et al. Early statin therapy restores endothelial function in children with familial hypercholesterolemia. , 2002, Journal of the American College of Cardiology.
[362] B. Davis,et al. Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). , 2002, JAMA.
[363] R. Collins,et al. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies , 2002, The Lancet.
[364] G. Holmes,et al. Screening for coeliac disease in type 1 diabetes , 2002, Archives of disease in childhood.
[365] C. Castaneda,et al. A randomized controlled trial of resistance exercise training to improve glycemic control in older adults with type 2 diabetes. , 2002, Diabetes care.
[366] S. Heller,et al. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial , 2002, BMJ : British Medical Journal.
[367] J. Shaw,et al. High-intensity resistance training improves glycemic control in older patients with type 2 diabetes. , 2002, Diabetes care.
[368] Catherine Kim,et al. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. , 2002, Diabetes care.
[369] N. Levinsky. Specialist Evaluation in Chronic Kidney Disease: Too Little, Too Late , 2002, Annals of Internal Medicine.
[370] Deepak L. Bhatt,et al. Amplified benefit of clopidogrel versus aspirin in patients with diabetes mellitus. , 2002, The American journal of cardiology.
[371] A. Ceriello,et al. Evidence for an Independent and Cumulative Effect of Postprandial Hypertriglyceridemia and Hyperglycemia on Endothelial Dysfunction and Oxidative Stress Generation: Effects of Short- and Long-Term Simvastatin Treatment , 2002, Circulation.
[372] K. Freedland,et al. Anxiety and Poor Glycemic Control: A Meta-Analytic Review of the Literature , 2002, International journal of psychiatry in medicine.
[373] T. Buchanan,et al. Preservation of pancreatic beta-cell function and prevention of type 2 diabetes by pharmacological treatment of insulin resistance in high-risk hispanic women. , 2002, Diabetes.
[374] S. Grundy,et al. Efficacy, safety, and tolerability of once-daily niacin for the treatment of dyslipidemia associated with type 2 diabetes: results of the assessment of diabetes control and evaluation of the efficacy of niaspan trial. , 2002, Archives of internal medicine.
[375] A. Graber,et al. Improving Glycemic Control in Adults With Diabetes Mellitus: Shared Responsibility in Primary Care Practices , 2002, Southern medical journal.
[376] H. Parving,et al. Effect of dietary protein restriction on prognosis in patients with diabetic nephropathy. , 2002, Kidney international.
[377] C. Schmid,et al. Self-management education for adults with type 2 diabetes: a meta-analysis of the effect on glycemic control. , 2002, Diabetes care.
[378] M. Laakso,et al. Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial , 2002, The Lancet.
[379] O. Kordonouri,et al. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[380] P. Cryer,et al. Hypoglycaemia: The limiting factor in the glycaemic management of Type I and Type II Diabetes* , 2002, Diabetologia.
[381] Steven Snapinn,et al. Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol , 2002, The Lancet.
[382] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[383] D. Goldstein,et al. Defining the relationship between plasma glucose and HbA(1c): analysis of glucose profiles and HbA(1c) in the Diabetes Control and Complications Trial. , 2002, Diabetes care.
[384] Carla K. Miller,et al. Nutrition education improves metabolic outcomes among older adults with diabetes mellitus: results from a randomized controlled trial. , 2002, Preventive medicine.
[385] G. Bakris,et al. Microalbuminuria: marker of vascular dysfunction, risk factor for cardiovascular disease , 2002, Vascular medicine.
[386] Terho Lehtimäki,et al. Carotid artery intima-media thickness in children with type 1 diabetes. , 2002, Diabetes.
[387] D. Kendall,et al. Assessment of group versus individual diabetes education: a randomized study. , 2002, Diabetes care.
[388] A. Mohn,et al. The effect of subclinical hypothyroidism on metabolic control in children and adolescents with Type 1 diabetes mellitus , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[389] Arshag D Mooradian,et al. Evidence-based nutrition principles and recommendations for the treatment and prevention of diabetes and related complications. , 2002, Diabetes care.
[390] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy , 2002 .
[391] American Gastroenterological Association medical position statement: nonalcoholic fatty liver disease. , 2002, Gastroenterology.
[392] B. Bistrian,et al. Intensive insulin therapy in critically ill patients. , 2002, The New England journal of medicine.
[393] R. Sigal,et al. Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta‐analysis of controlled clinical trials , 2002, JAMA.
[394] G Chatellier,et al. Is "isolated home" hypertension as opposed to "isolated office" hypertension a sign of greater cardiovascular risk? , 2001, Archives of internal medicine.
[395] M Schetz,et al. Intensive insulin therapy in critically ill patients. , 2001, The New England journal of medicine.
[396] B. Brenner,et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. , 2001, The New England journal of medicine.
[397] H. Parving,et al. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. , 2001, The New England journal of medicine.
[398] E. Lewis,et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. , 2001, The New England journal of medicine.
[399] D. Dunger,et al. Clinical and psychological course of diabetes from adolescence to young adulthood: a longitudinal cohort study. , 2001, Diabetes care.
[400] N. Hollenberg. ACE inhibition or angiotensin receptor blockade: impact on potassium in renal failure. , 2001, Current hypertension reports.
[401] L. Kuller,et al. Lipid and blood pressure treatment goals for type 1 diabetes: 10-year incidence data from the Pittsburgh Epidemiology of Diabetes Complications Study. , 2001, Diabetes care.
[402] K. Freedland,et al. The prevalence of comorbid depression in adults with diabetes: a meta-analysis. , 2001, Diabetes care.
[403] T. Valle,et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. , 2001, The New England journal of medicine.
[404] M Peyrot,et al. Psychological issues and treatments for people with diabetes. , 2001, Journal of clinical psychology.
[405] S. Norris,et al. Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials. , 2001, Diabetes care.
[406] P. Valensi,et al. Predictive value of cardiac autonomic neuropathy in diabetic patients with or without silent myocardial ischemia. , 2001, Diabetes care.
[407] J C Boyd,et al. Quality specifications for glucose meters: assessment by simulation modeling of errors in insulin dose. , 2001, Clinical chemistry.
[408] G. Bray,et al. Effects on blood pressure of reduced dietary sodium and the Dietary Approaches to Stop Hypertension (DASH) diet , 2001 .
[409] W. Assendelft,et al. Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings. , 2000, The Cochrane database of systematic reviews.
[410] T. Sano,et al. [Diabetic retinopathy]. , 2001, Nihon rinsho. Japanese journal of clinical medicine.
[411] P. D'Orazio,et al. IFCC recommendation on reporting results for blood glucose. , 2001, Clinica chimica acta; international journal of clinical chemistry.
[412] J. Mckenney,et al. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). , 2001, JAMA.
[413] M. Cooper,et al. Randomised controlled trial of dual blockade of renin-angiotensin system in patients with hypertension, microalbuminuria, and non-insulin dependent diabetes: the candesartan and lisinopril microalbuminuria (CALM) study , 2000, BMJ : British Medical Journal.
[414] D. Hunninghake,et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease: the ADMIT study: A randomized trial. Arterial Disease Multiple Intervention Trial. , 2000, JAMA.
[415] G. Bakris,et al. Preserving renal function in adults with hypertension and diabetes: a consensus approach. National Kidney Foundation Hypertension and Diabetes Executive Committees Working Group. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[416] R. Holman,et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study , 2000, BMJ : British Medical Journal.
[417] John S Yudkin,et al. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36): prospective observational study , 2000, BMJ : British Medical Journal.
[418] Diabetes Control. Effect of pregnancy on microvascular complications in the diabetes control and complications trial. The Diabetes Control and Complications Trial Research Group. , 2000, Diabetes care.
[419] J. Arnett. Emerging adulthood. A theory of development from the late teens through the twenties. , 2000, The American psychologist.
[420] Matthew D. Davis,et al. Retinopathy and nephropathy in patients with type 1 diabetes four years after a trial of intensive therapy. , 2000, The New England journal of medicine.
[421] Bruce H. R. Wolffenbuttel,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy , 2000, The Lancet.
[422] S Shepperd,et al. Discharge planning from hospital to home. , 2000, The Cochrane database of systematic reviews.
[423] Steven A. Smith,et al. Use of influenza and pneumococcal vaccines in people with diabetes. , 2000, Diabetes care.
[424] Illiam,et al. THE EFFECT OF NISOLDIPINE AS COMPARED WITH ENALAPRIL ON CARDIOVASCULAR OUTCOMES IN PATIENTS WITH NON-INSULIN-DEPENDENT DIABETES AND HYPERTENSION , 2000 .
[425] D. Nathan,et al. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. , 1999, Diabetes care.
[426] R. Holl,et al. Thyroid Autoimmunity in Children and Adolescents with Type 1 Diabetes mellitus , 1999, Hormone Research in Paediatrics.
[427] T. Wilt,et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.
[428] A. Donker,et al. The effect of protein restriction on albuminuria in patients with type 2 diabetes mellitus: a randomized trial. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[429] H Wedel,et al. Infarction : Long-Term Results From the Diabetes and Insulin-Glucose Infusion Conventionally Treated Patients With Diabetes Mellitus and Acute Myocardial Glycometabolic State at Admission : Important Risk Marker of Mortality in , 1999 .
[430] J. Viikari,et al. Serum cholesterol ester fatty acids in 7- and 13-month-old children in a prospective randomized trial of a low-saturated fat, low-cholesterol diet: the STRIP baby project. Special Turku coronary Risk factor Intervention Project for children. , 1999 .
[431] J. Viikari,et al. Serum cholesterol ester fatty acids in 7‐ and 13‐month‐old children in a prospective randomized trial of a low‐saturated fat, low‐cholesterol diet: the STRIP baby project , 1999, Acta paediatrica.
[432] A. Levey,et al. A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation , 1999, Annals of Internal Medicine.
[433] R. Barrio,et al. Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus. , 1999, Diabetes, nutrition & metabolism.
[434] P. O S I T I O N S T A T E M E N T. Diabetes Care in the School and Day Care Setting , 2010, Diabetes Care.
[435] B. Davis,et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.
[436] Philip D. Harvey,et al. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 , 1998, BMJ.
[437] R. Holman,et al. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. , 1998 .
[438] R. Holman,et al. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34) , 1998, The Lancet.
[439] Joël Ménard,et al. Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial , 1998, The Lancet.
[440] T A Louis,et al. A meta-analysis of the effects of dietary protein restriction on the rate of decline in renal function. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[441] R. Newton,et al. The comparison of four weight reduction strategies aimed at overweight patients with diabetes mellitus: four‐year follow‐up , 1998, Diabetic medicine : a journal of the British Diabetic Association.
[442] R. Schrier,et al. Overt albuminuria predicts diabetic retinopathy in Hispanics with NIDDM. , 1998, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[443] M. Pahor,et al. Outcome Results of the Fosinopril Versus Amlodipine Cardiovascular Events Randomized Trial (FACET) in Patients With Hypertension and NIDDM , 1998, Diabetes Care.
[444] D. Andrewes,et al. Neuropsychological Complications of IDDM in Children 2 Years After Disease Onset , 1998, Diabetes Care.
[445] J. Kendrick. Preconception Care of Women With Diabetes , 1998, Diabetes Care.
[446] J. L. Botha,et al. Effectiveness of influenza vaccine in reducing hospital admissions in people with diabetes , 1997, Epidemiology and Infection.
[447] M. Fantone,et al. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus , 1997, Diabetes Care.
[448] J. Rovet,et al. Attentional Functioning in Children and Adolescents With IDDM , 1997, Diabetes Care.
[449] G. Bray,et al. A clinical trial of the effects of dietary patterns on blood pressure. DASH Collaborative Research Group. , 1997, The New England journal of medicine.
[450] Terje R Pedersen,et al. Cholesterol Lowering With Simvastatin Improves Prognosis of Diabetic Patients With Coronary Heart Disease: A subgroup analysis of the Scandinavian Simvastatin Survival Study (4S) , 1997, Diabetes Care.
[451] B. Howard,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance: The Da Qing IGT and Diabetes Study , 1997, Diabetes Care.
[452] H. Parving,et al. Risk factors for development of incipient and overt diabetic nephropathy in patients with non-insulin dependent diabetes mellitus: prospective, observational study , 1997, BMJ.
[453] B. Psaty,et al. Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis. , 1997, JAMA.
[454] T. Sand,et al. Cognitive function in Type 1 diabetic children with and without episodes of severe hypoglycaemia , 1997, Acta paediatrica.
[455] B. Davis,et al. Effect of diuretic-based antihypertensive treatment on cardiovascular disease risk in older diabetic patients with isolated systolic hypertension. Systolic Hypertension in the Elderly Program Cooperative Research Group. , 1996, JAMA.
[456] B. Sibai. Treatment of hypertension in pregnant women. , 1996, The New England journal of medicine.
[457] M. Lishner,et al. Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study. , 1996, Archives of internal medicine.
[458] J. McGill,et al. The beneficial effect of angiotensin-converting enzyme inhibition with captopril on diabetic nephropathy in normotensive IDDM patients with microalbuminuria. North American Microalbuminuria Study Group. , 1995, The American journal of medicine.
[459] R. Bergenstal,et al. Effectiveness of medical nutrition therapy provided by dietitians in the management of non-insulin-dependent diabetes mellitus: a randomized, controlled clinical trial. , 1995, Journal of the American Dietetic Association.
[460] N. Santanello,et al. Efficacy and safety of lowering dietary intake of fat and cholesterol in children with elevated low-density lipoprotein cholesterol: The dietary intervention study in children (DISC) , 1995 .
[461] E. Araki,et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. , 1995, Diabetes research and clinical practice.
[462] R. Klein. Hyperglycemie and Microvascular and Macrovascular Disease in Diabetes , 1995, Diabetes Care.
[463] Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial. The Diabetes Control and Complications (DCCT) Research Group. , 1995, Kidney international.
[464] A Fournier,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. , 1994, The New England journal of medicine.
[465] R. Bain,et al. The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group. , 1993, The New England journal of medicine.
[466] S. Genuth,et al. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. , 1993, The New England journal of medicine.
[467] P. Reichard,et al. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. , 1993, The New England journal of medicine.
[468] J. Neaton,et al. Diabetes, Other Risk Factors, and 12-Yr Cardiovascular Mortality for Men Screened in the Multiple Risk Factor Intervention Trial , 1993, Diabetes Care.
[469] H. Chase,et al. Thyroid Hormone Replacement and Growth of Children with Subclinical Hypothyroidism and Diabetes , 1990, Diabetic medicine : a journal of the British Diabetic Association.
[470] P. O S I T I O N S T A T E M E N T. Diabetes Management in Correctional Institutions , 2006, Diabetes Care.
[471] C. Jf,et al. [Diabetic autonomic neuropathy]. , 1989, Atencion primaria.
[472] Clifford Goodman,et al. American Academy of Physical Medicine and Rehabilitation , 1988 .
[473] J. Huttunen,et al. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease. , 1987, The New England journal of medicine.
[474] J. Stamler,et al. Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin. , 1986, Journal of the American College of Cardiology.
[475] Photocoagulation for diabetic macular edema. Early Treatment Diabetic Retinopathy Study report number 1. Early Treatment Diabetic Retinopathy Study research group. , 1985, Archives of ophthalmology.
[476] Dang Qing,et al. Effects of Diet and Exercise in Preventing NIDDM in People With Impaired Glucose Tolerance The , 2022 .
[477] Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes : a randomised placebo-controlled trial , 2022 .